Basic Information


GTO ID GTC0124
Trial ID NCT01460901
Disease Neuroblastoma
Altered gene GD2
Therapeutic/Target gene Target gene
TherapyCAR-T cell
Treatment GD2 CAR-T cells
PhasePhase1
Recruitment statusCompleted
TitleStudy of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma
Year2011
CountryUnited States
Company sponsorChildren's Mercy Hospital Kansas City
Other ID(s)STALLONe|00038
Vector information
Vectorretrovirus

Clinical Result

Cohort 1
Administration route None
Dosage 2E6 cells/m^2, single infusion
Donor type Allogeneic
Pts 3
Age Child
Adverse reactions 3/3(All-couse mortality)

Relationship Graph

Overview of Knowledge Graph